世界のクラッベ病治療薬市場インサイト及び予測(~2026年)

【英語タイトル】Global Krabbe Disease Drugs Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(QYR20NV12466)・商品コード:QYR20NV12466
・発行会社(調査会社):QYResearch
・発行日:2020年11月
・ページ数:94
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥421,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥631,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥842,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはクラッベ病治療薬の世界市場について調査・分析した資料です。種類別(抗けいれん薬、筋弛緩薬、その他)の市場規模、用途別(病院、クリニック、研究センター、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別クラッベ病治療薬の競争状況、市場シェア
・世界のクラッベ病治療薬市場:種類別市場規模 2015年-2020年(抗けいれん薬、筋弛緩薬、その他)
・世界のクラッベ病治療薬市場:種類別市場規模予測 2021年-2026年(抗けいれん薬、筋弛緩薬、その他)
・世界のクラッベ病治療薬市場:用途別市場規模 2015年-2020年(病院、クリニック、研究センター、その他)
・世界のクラッベ病治療薬市場:用途別市場規模予測 2021年-2026年(病院、クリニック、研究センター、その他)
・北米のクラッベ病治療薬市場分析:米国、カナダ
・ヨーロッパのクラッベ病治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのクラッベ病治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のクラッベ病治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのクラッベ病治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):GlaxoSmithKline、Johnson & Johnson、Novartis、Pfizer、Sanofi、Abbott Laboratories、Teva Pharmaceutical、Takeda、UCB Pharmaceuticals
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to make myelin in a human body.
Globally North America is the largest market for Krabbe disease treatment. Europe is the second-largest market and Asia Pacific is expected to grow at a fastest rate.

Market Analysis and Insights: Global Krabbe Disease Drugs Market
The global Krabbe Disease Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Krabbe Disease Drugs Scope and Market Size
Krabbe Disease Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Krabbe Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
GlaxoSmithKline
Johnson & Johnson
Novartis
Pfizer
Sanofi
Abbott Laboratories
Teva Pharmaceutical
Takeda
UCB Pharmaceuticals

Market segment by Type, the product can be split into
Anticonvulsants
Muscle Relaxants
Others
Market segment by Application, split into
Hospitals
Clinics
Research Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Krabbe Disease Drugs Revenue
1.4 Market by Type
1.4.1 Global Krabbe Disease Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anticonvulsants
1.4.3 Muscle Relaxants
1.4.4 Others
1.5 Market by Application
1.5.1 Global Krabbe Disease Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Krabbe Disease Drugs Market Perspective (2015-2026)
2.2 Global Krabbe Disease Drugs Growth Trends by Regions
2.2.1 Krabbe Disease Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Krabbe Disease Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Krabbe Disease Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Krabbe Disease Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Krabbe Disease Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Krabbe Disease Drugs Players by Market Size
3.1.1 Global Top Krabbe Disease Drugs Players by Revenue (2015-2020)
3.1.2 Global Krabbe Disease Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Krabbe Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Krabbe Disease Drugs Market Concentration Ratio
3.2.1 Global Krabbe Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Krabbe Disease Drugs Revenue in 2019
3.3 Krabbe Disease Drugs Key Players Head office and Area Served
3.4 Key Players Krabbe Disease Drugs Product Solution and Service
3.5 Date of Enter into Krabbe Disease Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Krabbe Disease Drugs Historic Market Size by Type (2015-2020)
4.2 Global Krabbe Disease Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Krabbe Disease Drugs Market Size by Application (2015-2020)
5.2 Global Krabbe Disease Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Krabbe Disease Drugs Market Size (2015-2020)
6.2 Krabbe Disease Drugs Key Players in North America (2019-2020)
6.3 North America Krabbe Disease Drugs Market Size by Type (2015-2020)
6.4 North America Krabbe Disease Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Krabbe Disease Drugs Market Size (2015-2020)
7.2 Krabbe Disease Drugs Key Players in Europe (2019-2020)
7.3 Europe Krabbe Disease Drugs Market Size by Type (2015-2020)
7.4 Europe Krabbe Disease Drugs Market Size by Application (2015-2020)

8 China
8.1 China Krabbe Disease Drugs Market Size (2015-2020)
8.2 Krabbe Disease Drugs Key Players in China (2019-2020)
8.3 China Krabbe Disease Drugs Market Size by Type (2015-2020)
8.4 China Krabbe Disease Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Krabbe Disease Drugs Market Size (2015-2020)
9.2 Krabbe Disease Drugs Key Players in Japan (2019-2020)
9.3 Japan Krabbe Disease Drugs Market Size by Type (2015-2020)
9.4 Japan Krabbe Disease Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Krabbe Disease Drugs Market Size (2015-2020)
10.2 Krabbe Disease Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Krabbe Disease Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Krabbe Disease Drugs Market Size by Application (2015-2020)

11 India
11.1 India Krabbe Disease Drugs Market Size (2015-2020)
11.2 Krabbe Disease Drugs Key Players in India (2019-2020)
11.3 India Krabbe Disease Drugs Market Size by Type (2015-2020)
11.4 India Krabbe Disease Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Krabbe Disease Drugs Market Size (2015-2020)
12.2 Krabbe Disease Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Krabbe Disease Drugs Market Size by Type (2015-2020)
12.4 Central & South America Krabbe Disease Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Krabbe Disease Drugs Introduction
13.1.4 GlaxoSmithKline Revenue in Krabbe Disease Drugs Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Krabbe Disease Drugs Introduction
13.2.4 Johnson & Johnson Revenue in Krabbe Disease Drugs Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Krabbe Disease Drugs Introduction
13.3.4 Novartis Revenue in Krabbe Disease Drugs Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Krabbe Disease Drugs Introduction
13.4.4 Pfizer Revenue in Krabbe Disease Drugs Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Krabbe Disease Drugs Introduction
13.5.4 Sanofi Revenue in Krabbe Disease Drugs Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Abbott Laboratories
13.6.1 Abbott Laboratories Company Details
13.6.2 Abbott Laboratories Business Overview
13.6.3 Abbott Laboratories Krabbe Disease Drugs Introduction
13.6.4 Abbott Laboratories Revenue in Krabbe Disease Drugs Business (2015-2020)
13.6.5 Abbott Laboratories Recent Development
13.7 Teva Pharmaceutical
13.7.1 Teva Pharmaceutical Company Details
13.7.2 Teva Pharmaceutical Business Overview
13.7.3 Teva Pharmaceutical Krabbe Disease Drugs Introduction
13.7.4 Teva Pharmaceutical Revenue in Krabbe Disease Drugs Business (2015-2020)
13.7.5 Teva Pharmaceutical Recent Development
13.8 Takeda
13.8.1 Takeda Company Details
13.8.2 Takeda Business Overview
13.8.3 Takeda Krabbe Disease Drugs Introduction
13.8.4 Takeda Revenue in Krabbe Disease Drugs Business (2015-2020)
13.8.5 Takeda Recent Development
13.9 UCB Pharmaceuticals
13.9.1 UCB Pharmaceuticals Company Details
13.9.2 UCB Pharmaceuticals Business Overview
13.9.3 UCB Pharmaceuticals Krabbe Disease Drugs Introduction
13.9.4 UCB Pharmaceuticals Revenue in Krabbe Disease Drugs Business (2015-2020)
13.9.5 UCB Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Krabbe Disease Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Krabbe Disease Drugs Revenue
Table 3. Ranking of Global Top Krabbe Disease Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Krabbe Disease Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anticonvulsants
Table 6. Key Players of Muscle Relaxants
Table 7. Key Players of Others
Table 8. Global Krabbe Disease Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Krabbe Disease Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Krabbe Disease Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Krabbe Disease Drugs Market Share by Regions (2015-2020)
Table 12. Global Krabbe Disease Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Krabbe Disease Drugs Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Krabbe Disease Drugs Market Growth Strategy
Table 18. Main Points Interviewed from Key Krabbe Disease Drugs Players
Table 19. Global Krabbe Disease Drugs Revenue by Players (2015-2020) (Million US$)
Table 20. Global Krabbe Disease Drugs Market Share by Players (2015-2020)
Table 21. Global Top Krabbe Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Krabbe Disease Drugs as of 2019)
Table 22. Global Krabbe Disease Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Krabbe Disease Drugs Product Solution and Service
Table 25. Date of Enter into Krabbe Disease Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Krabbe Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 28. Global Krabbe Disease Drugs Market Size Share by Type (2015-2020)
Table 29. Global Krabbe Disease Drugs Revenue Market Share by Type (2021-2026)
Table 30. Global Krabbe Disease Drugs Market Size Share by Application (2015-2020)
Table 31. Global Krabbe Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 32. Global Krabbe Disease Drugs Market Size Share by Application (2021-2026)
Table 33. North America Key Players Krabbe Disease Drugs Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Krabbe Disease Drugs Market Share (2019-2020)
Table 35. North America Krabbe Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 36. North America Krabbe Disease Drugs Market Share by Type (2015-2020)
Table 37. North America Krabbe Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. North America Krabbe Disease Drugs Market Share by Application (2015-2020)
Table 39. Europe Key Players Krabbe Disease Drugs Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Krabbe Disease Drugs Market Share (2019-2020)
Table 41. Europe Krabbe Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Krabbe Disease Drugs Market Share by Type (2015-2020)
Table 43. Europe Krabbe Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Krabbe Disease Drugs Market Share by Application (2015-2020)
Table 45. China Key Players Krabbe Disease Drugs Revenue (2019-2020) (Million US$)
Table 46. China Key Players Krabbe Disease Drugs Market Share (2019-2020)
Table 47. China Krabbe Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. China Krabbe Disease Drugs Market Share by Type (2015-2020)
Table 49. China Krabbe Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. China Krabbe Disease Drugs Market Share by Application (2015-2020)
Table 51. Japan Key Players Krabbe Disease Drugs Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Krabbe Disease Drugs Market Share (2019-2020)
Table 53. Japan Krabbe Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Krabbe Disease Drugs Market Share by Type (2015-2020)
Table 55. Japan Krabbe Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Krabbe Disease Drugs Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Krabbe Disease Drugs Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Krabbe Disease Drugs Market Share (2019-2020)
Table 59. Southeast Asia Krabbe Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Krabbe Disease Drugs Market Share by Type (2015-2020)
Table 61. Southeast Asia Krabbe Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Krabbe Disease Drugs Market Share by Application (2015-2020)
Table 63. India Key Players Krabbe Disease Drugs Revenue (2019-2020) (Million US$)
Table 64. India Key Players Krabbe Disease Drugs Market Share (2019-2020)
Table 65. India Krabbe Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. India Krabbe Disease Drugs Market Share by Type (2015-2020)
Table 67. India Krabbe Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. India Krabbe Disease Drugs Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Krabbe Disease Drugs Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Krabbe Disease Drugs Market Share (2019-2020)
Table 71. Central & South America Krabbe Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Krabbe Disease Drugs Market Share by Type (2015-2020)
Table 73. Central & South America Krabbe Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Krabbe Disease Drugs Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Revenue in Krabbe Disease Drugs Business (2015-2020) (Million US$)
Table 79. GlaxoSmithKline Recent Development
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Product
Table 83. Johnson & Johnson Revenue in Krabbe Disease Drugs Business (2015-2020) (Million US$)
Table 84. Johnson & Johnson Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Krabbe Disease Drugs Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Product
Table 93. Pfizer Revenue in Krabbe Disease Drugs Business (2015-2020) (Million US$)
Table 94. Pfizer Recent Development
Table 95. Sanofi Company Details
Table 96. Sanofi Business Overview
Table 97. Sanofi Product
Table 98. Sanofi Revenue in Krabbe Disease Drugs Business (2015-2020) (Million US$)
Table 99. Sanofi Recent Development
Table 100. Abbott Laboratories Company Details
Table 101. Abbott Laboratories Business Overview
Table 102. Abbott Laboratories Product
Table 103. Abbott Laboratories Revenue in Krabbe Disease Drugs Business (2015-2020) (Million US$)
Table 104. Abbott Laboratories Recent Development
Table 105. Teva Pharmaceutical Company Details
Table 106. Teva Pharmaceutical Business Overview
Table 107. Teva Pharmaceutical Product
Table 108. Teva Pharmaceutical Revenue in Krabbe Disease Drugs Business (2015-2020) (Million US$)
Table 109. Teva Pharmaceutical Recent Development
Table 110. Takeda Business Overview
Table 111. Takeda Product
Table 112. Takeda Company Details
Table 113. Takeda Revenue in Krabbe Disease Drugs Business (2015-2020) (Million US$)
Table 114. Takeda Recent Development
Table 115. UCB Pharmaceuticals Company Details
Table 116. UCB Pharmaceuticals Business Overview
Table 117. UCB Pharmaceuticals Product
Table 118. UCB Pharmaceuticals Revenue in Krabbe Disease Drugs Business (2015-2020) (Million US$)
Table 119. UCB Pharmaceuticals Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Krabbe Disease Drugs Market Share by Type: 2020 VS 2026
Figure 2. Anticonvulsants Features
Figure 3. Muscle Relaxants Features
Figure 4. Others Features
Figure 5. Global Krabbe Disease Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Krabbe Disease Drugs Report Years Considered
Figure 11. Global Krabbe Disease Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Krabbe Disease Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Krabbe Disease Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Krabbe Disease Drugs Market Share by Players in 2019
Figure 16. Global Top Krabbe Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Krabbe Disease Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Krabbe Disease Drugs Revenue in 2019
Figure 18. North America Krabbe Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Krabbe Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Krabbe Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Krabbe Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Krabbe Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Krabbe Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Krabbe Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed


【掲載企業】

GlaxoSmithKline、Johnson & Johnson、Novartis、Pfizer、Sanofi、Abbott Laboratories、Teva Pharmaceutical、Takeda、UCB Pharmaceuticals

★調査レポート[世界のクラッベ病治療薬市場インサイト及び予測(~2026年)] (コード:QYR20NV12466)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のクラッベ病治療薬市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆